Clinical trial
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000199 · University of Pennsylvania, Other · Withdrawn
Key facts
| NCT number | NCT00000199 |
|---|---|
| Title | Piracetam for Treatment of Cocaine Addiction, Phase II - 4 |
| Official title | Piracetam for Treatment of Cocaine Addiction, Phase II |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Piracetam |
| Enrollment | 0 |
| First posted | Sep 21, 1999 |
| Last update posted | Mar 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: